These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 35290656)
1. Role of drug delivery technologies in the success of COVID-19 vaccines: a perspective. Labouta HI; Langer R; Cullis PR; Merkel OM; Prausnitz MR; Gomaa Y; Nogueira SS; Kumeria T Drug Deliv Transl Res; 2022 Nov; 12(11):2581-2588. PubMed ID: 35290656 [TBL] [Abstract][Full Text] [Related]
2. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases. Pilkington EH; Suys EJA; Trevaskis NL; Wheatley AK; Zukancic D; Algarni A; Al-Wassiti H; Davis TP; Pouton CW; Kent SJ; Truong NP Acta Biomater; 2021 Sep; 131():16-40. PubMed ID: 34153512 [TBL] [Abstract][Full Text] [Related]
3. Current Status and Future Perspectives on MRNA Drug Manufacturing. Webb C; Ip S; Bathula NV; Popova P; Soriano SKV; Ly HH; Eryilmaz B; Nguyen Huu VA; Broadhead R; Rabel M; Villamagna I; Abraham S; Raeesi V; Thomas A; Clarke S; Ramsay EC; Perrie Y; Blakney AK Mol Pharm; 2022 Apr; 19(4):1047-1058. PubMed ID: 35238565 [TBL] [Abstract][Full Text] [Related]
4. Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2. Granados-Riveron JT; Aquino-Jarquin G Biomed Pharmacother; 2021 Oct; 142():111953. PubMed ID: 34343897 [TBL] [Abstract][Full Text] [Related]
5. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism. Amanpour S Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952 [TBL] [Abstract][Full Text] [Related]
6. Learning lessons from lipids to make COVID-19 vaccines. Cell; 2022 Apr; 185(8):1279-1282. PubMed ID: 35385689 [TBL] [Abstract][Full Text] [Related]
8. An overview of lipid constituents in lipid nanoparticle mRNA delivery systems. Wu S; Lin L; Shi L; Liu S Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(4):e1978. PubMed ID: 38965928 [TBL] [Abstract][Full Text] [Related]
9. A Basic Method for Formulating mRNA-Lipid Nanoparticle Vaccines in the Lab. Jarzebska NT; Frei J; Mellett M; Kündig TM; Pascolo S; Reichmuth AM Methods Mol Biol; 2024; 2786():237-254. PubMed ID: 38814398 [TBL] [Abstract][Full Text] [Related]
10. Chemistry of Lipid Nanoparticles for RNA Delivery. Eygeris Y; Gupta M; Kim J; Sahay G Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635 [TBL] [Abstract][Full Text] [Related]
11. Innovative vaccine platforms against infectious diseases: Under the scope of the COVID-19 pandemic. Tsakiri M; Naziris N; Demetzos C Int J Pharm; 2021 Dec; 610():121212. PubMed ID: 34687816 [TBL] [Abstract][Full Text] [Related]
12. Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective [Invited]. Jawalagatti V; Kirthika P; Lee JH Front Immunol; 2022; 13():884862. PubMed ID: 35592330 [TBL] [Abstract][Full Text] [Related]
13. Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines. Szebeni J; Storm G; Ljubimova JY; Castells M; Phillips EJ; Turjeman K; Barenholz Y; Crommelin DJA; Dobrovolskaia MA Nat Nanotechnol; 2022 Apr; 17(4):337-346. PubMed ID: 35393599 [TBL] [Abstract][Full Text] [Related]
15. Principles for designing an optimal mRNA lipid nanoparticle vaccine. Kon E; Elia U; Peer D Curr Opin Biotechnol; 2022 Feb; 73():329-336. PubMed ID: 34715546 [TBL] [Abstract][Full Text] [Related]
16. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency. Anderluzzi G; Lou G; Woods S; Schmidt ST; Gallorini S; Brazzoli M; Johnson R; Roberts CW; O'Hagan DT; Baudner BC; Perrie Y J Control Release; 2022 Feb; 342():388-399. PubMed ID: 34896446 [TBL] [Abstract][Full Text] [Related]
18. What Do COVID-19 Vaccines Tell Us About Nucleic Acid Delivery Hadjiargyrou M Nucleic Acid Ther; 2021 Oct; 31(5):321-323. PubMed ID: 33960839 [TBL] [Abstract][Full Text] [Related]
19. Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose. Nevo L; Cahen-Peretz A; Vorontsov O; Frenkel R; Kabessa M; Cohen SM; Hamrani A; Oiknine-Djian E; Lipschuetz M; Goldman-Wohl D; Walfisch A; Kovo M; Neeman M; Yagel S; Wolf DG; Beharier O Am J Obstet Gynecol; 2022 Sep; 227(3):486.e1-486.e10. PubMed ID: 35430228 [TBL] [Abstract][Full Text] [Related]
20. Low energy nebulization preserves integrity of SARS-CoV-2 mRNA vaccines for respiratory delivery. van Rijn CJM; Vlaming KE; Bem RA; Dekker RJ; Poortinga A; Breit T; van Leeuwen S; Ensink WA; van Wijnbergen K; van Hamme JL; Bonn D; Geijtenbeek TBH Sci Rep; 2023 May; 13(1):8851. PubMed ID: 37258559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]